Loading organizations...

§ Private Profile · Trieste, Italy
Recornea is a technology company.
Recornea is a clinical-stage ophthalmic medtech company that develops advanced therapeutic solutions for diseases of the eye. Its core product is the GROSSO® Reshaper, identified as the world's first nitinol intracorneal implant. This device offers a specialized medical approach to address various ocular conditions requiring precise and innovative intervention.
The company emerged from the medical technology sector, founded on an insight into improving treatments for corneal disorders. While specific founder details are not widely available, Recornea's establishment was driven by a commitment to advancing eye care through novel device development and material science applications.
Recornea targets patients affected by eye diseases that can benefit from its implant technology, aiming to provide impactful treatment options. The company's vision is to deliver effective, affordable, and accessible ophthalmic care, ultimately improving visual health and setting a new standard in the field of eye medicine.
Recornea has raised $1.6M across 3 funding rounds.
Recornea has raised $1.6M in total across 3 funding rounds.
Recornea has raised $1.6M in total across 3 funding rounds.
Recornea's investors include ENEA Tech e Biomedical, B-Heroes, Caique Holding, DN Lemans, Entrepreneur First, G-Factor, Health Wildcatters, Scientifica Venture Capital, Riccardo D'Alessandri.
Recornea is a clinical-stage medtech company building nitinol‑based ophthalmic implants to restore corneal shape and vision—most notably the GROSSO® Reshaper for keratoconus—and is advancing through first‑in‑human trials and seed/early rounds to move toward larger pivotal studies and commercialization in Europe[1][2].
High‑Level Overview
For a portfolio/operating snapshot:
Origin Story
Core Differentiators
Role in the Broader Tech & Medtech Landscape
Quick Take & Future Outlook
If you’d like, I can:
Recornea has raised $1.6M across 3 funding rounds. Most recently, it raised $1.4M Seed in August 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 7, 2025 | $1.4M Seed | Enea Tech E Biomedical | B Heroes, Caique Holding, DN Lemans, Entrepreneur First, G Factor, Health Wildcatters, Scientifica Venture Capital | Announced |
| Jun 27, 2024 | $160K Venture Round | Riccardo D'alessandri | — | Announced |
| Sep 1, 2021 | $30K Seed | — | Health Wildcatters | Announced |